X
Email:
sales@ruixibiotech.com

TTQ-F- PEG-RGD

4,9-bis(5-bromothiophen-2-yl)-6,7-bis(4-(hexyloxy)phenyl)-[1,2,5]thiadiazolo[3,4-g]quinoxaline-polyethylene glycol-RGD

Catalog # Pkg Size Price(USD) Quantity Buy this product
R-M-464 10mg 800.00
- +
+ Add to cart
R-M-464 20mg 975.00
- +
+ Add to cart
  •     PEG Molecular Weight    
  •   

Product description

TTQ-PEG-RGD,4,9-bis(5-bromothiophen-2-yl)-6,7-bis(4-(hexyloxy)phenyl)-[1,2,5]thiadiazolo[3,4-g]quinoxaline-polyethylene glycol-RGD from ruixi.TTQ-PEG-RGD has high nir-ii strength, good stability and affinity for activated platelets. It can be used to target glioma and thrombus, and distinguish fresh thrombus from old thrombus. It can also specifically target thrombosis in vivo and in vitro, which provides a potential tool for noninvasive diagnosis of early thrombosis.


Appearance N/A
PEG Molecular weight 1000/2000/3400/5000/10000 Dalton
Purity >90%
Solubility N/A
PDI by GPC <1.5
Abs 739 nm
Em 997 nm
Storage -20℃, protected from light and moisture
Transportation 4-25℃ temperature for up to 2 weeks
Stability 1 year
Document

Related Product